Demo
AMS NYSE AM· American Shared Hospital Services
FundamentalsNews digest Peer analysis
Login
AMS NYSE AM· American Shared Hospital Services
Earnings report Q3 2023

AMS Reports Increase in Revenues for Q3 2023

Segments of Revenue

AMS reported a total revenue increase of $306,000 and $918,000 for the three and nine-month periods ended September 30, 2023, compared to the same periods in the prior year. Revenues from the domestic segment increased by $45,000 and $805,000 to $4,146,000 and $13,187,000 for the three and nine-month periods, respectively. Revenues from the international segment increased by $261,000 and $113,000 to $988,000 and $2,440,000 for the same periods.

Strengths

AMS demonstrated overall revenue growth in Q3 2023, with an increase of $306,000 compared to the prior year. The domestic segment contributed significantly to this growth, with a $45,000 increase in revenues. The management comments indicate that the increase in domestic segment revenues can be attributed to improved market conditions and successful execution of business strategies. Additionally, the international segment also showed positive growth, with a $261,000 increase in revenues, indicating the company's ability to expand its presence in global markets.

Challenges

Despite the overall revenue growth, AMS experienced a decrease in revenues generated from the PBRT system by $139,000. This decline may pose a challenge for the company, as it indicates a potential slowdown in demand for PBRT services. Further analysis is required to determine the underlying reasons for this decrease and its potential impact on the company's future performance.

Noteworthy

AMS recognized net revenue of $200,000 from the sale of equipment during the three and nine-month periods ended September 30, 2023. This indicates a successful monetization of assets and diversification of revenue streams. Additionally, the company's patient income, particularly from Gamma Knife treatments, remained consistent and contributed to overall revenue growth.

Summary

AMS reported an increase in revenues for Q3 2023, with a total revenue growth of $306,000 compared to the prior year. The domestic segment and international segment both contributed to this growth, showcasing the company's ability to capitalize on improved market conditions and expand its global presence. However, AMS faced a challenge with a decrease in revenues generated from the PBRT system, which requires further investigation. Overall, AMS demonstrated strength in its revenue performance, driven by successful execution of business strategies and consistent patient income.

Source documents

Form 10-Q  filed on Nov 14, 2023
95 pages scanned

Reference data

Company financials Q3 revenue 5.1M
Analyst estimates Q3 EPS missed by NaN%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.